Inhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytes

Journal of Physiology

Volumn 566, Issue 2, 2005, Pages 327-340

  Yu, Xin Wen ^a   Chen, Qian ^b   Kennedy, Richard H ^c   Liu, Shi J ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5,6 DIHYDRO 6 METHYL 4H 1,3 THIAZINE; CAFFEINE; CALCIUM CHANNEL; CALCIUM ION; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHOLAMBAN; UNCLASSIFIED DRUG; CALCIUM; CALCIUM CHANNEL L TYPE; NITRIC OXIDE; POTASSIUM; SODIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE; MALE; MEMBRANE STEADY POTENTIAL; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SARCOPLASMIC RETICULUM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; ADULT; ANIMAL EXPERIMENT; DRUG ACTIVITY; INOTROPISM; KINETICS;

ANIMALS; ANTIBODIES, BLOCKING; BLOTTING, WESTERN; CAFFEINE; CALCIUM; CALCIUM-BINDING PROTEINS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOWN-REGULATION; ENZYME ACTIVATION; INTERLEUKIN-6; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SARCOPLASMIC RETICULUM;

EID: 22744454951     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.086686     Document Type: Article

References (62)

1. 2+ current in rat ventricular myocytes. J Physiol 531, 117-130.
2. Akira S, Hirano T, Taga T & Kishimoto T (1990). Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 4, 2860-2867.
3. Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW & Michel T (1995). Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 270, 14582-14586.
4. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JAC, Berkowitz DE & Hare JM (2002). Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416, 337-339.
5. Bassani JWM, Bassani RA & Bers DM (1993). Twitch-dependent SR Ca accumulation and release in rabbit ventricular myocytes. Am J Physiol Cell Physiol 265, C533-540.
6. Bassani JWM, Bassani RA & Bers DM (1994). Relaxation in rabbit and rat cardiac cells: Species-dependent differences in cellular mechanisms. J Physiol 476, 279-293.
7. Bers DM, Li L, Satoh H & McCall E (1998). Factors that control sarcoplasmic reticulum calcium release in intact ventricular myocytes. Ann NY Acad Sci 853, 157-177.
8. Brady AJ, Poole-Wilson PA, Harding SE & Warren JB (1992). Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol Heart Circ Physiol 263, H1963-1966.
9. Campbell DL, Stamler JS & Strauss HC (1996). Redox modulation of L-type calcium channels in ferret ventricular myocytes - Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 108, 277-293.
10. Cesari M, Penninx BWJH, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB & Pahor M (2003). Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108, 2317-2322.
11. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hatttler BG & Simmons RL (1992). Negative inotropic effects of cytokines on the heart mediated nitric oxide. Science 257, 387-389.
12. French S, Giulivi C & Balaban RS (2001). Nitric oxide synthase in porcine heart mitochondria: evidence for low physiological activity. Am J Physiol Heart Circ Physiol 280, H2863-2867.
13. Gallo MP, Ghigo D, Bosia A, Alloatti G, Costamagna C, Penna C & Levi RC (1998). Modulation of guinea-pig cardiac L-type calcium current by nitric oxide synthase inhibitors. J Physiol 506, 639-651.
14. Guillén I, Blanes M, Gómez-Lechón M-J & Castell JV (1995). Cytokine signaling during myocardial infarction: Sequential appearance of IL-1β and IL-6. Am J Physiol Regul Integr Comp Physiol 269, R229-235.
15. Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG & Aarden LA (1989). Increased plasma levels of interleukin-6 in sepsis. Blood 74, 1704-1710.
16. Hamill OP, Neher E, Sakmann B & Sigworth FJ (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391, 85-100.
17. Hare JM (2003). Nitric oxide and excitation-contraction coupling. J Mol Cell Cardiol 35, 719-729.
18. Heger J, Gödecke A, Flögel U, Merx MW, Molojavyi A, Kühn-Velten WN & Schrader J (2002). Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ Res 90, 93-99.
19. Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, Kawai T & Shimada K (1992). Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 24, 579-584.
20. 2+-ATPase by nitric oxide. FEBS Lett 440, 218-222.
21. Janssen SPM, Gayan-Ramirez G, Van Den Bergh A, Herijgers P, Maes K, Verbeken E & Decramer M (2005). Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111, 996-1005.
22. Kanai AJ, Pearce LL, Clemens PR, Birder LA, VanBibber MM, Choi SY, De Groat WC & Peterson J (2001). Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci U S A 98, 14126-14131.
23. Kanda T & Takahashi T (2004). Interleukin-6 and cardiovascular diseases. Jpn Heart J 45, 183-193.
24. Khan SA, Skaf MW, Harrison RW, Lee K, Minhas KM, Kumar A, Fradley M, Shoukas AA, Berkowitz DE & Hare JM (2003). Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res 92, 1322-1329.
25. i and cell contraction in cultured chick ventricular myocytes. Circ Res 75, 285-295.
26. Kishimoto T, akira S, Narazaki M & Taga T (1995). Interleukin-6 family of cytokines and gp130. Blood 86, 1243-1254.
27. Koss KL & Kranias EG (1996). Phospholamban: a prominent regulator of myocardial contractility. Circ Res 79, 1059-1063.
28. Kuschel M, Karczewski P, Hempel P, Schlegel WP, Krause EG & Bartel S (1999). Ser16 prevails over Thr17 phospholamban phosphorylation in the beta-adrenergic regulation of cardiac relaxation. Am J Physiol Heart Circ Physiol 276, H1625-1633.
29. 2+ cycling by lysoplasmenylcholine in adult rabbit ventricular myocytes. Am J Physiol Cell Physiol 284, C826-838.
30. 2 isoforms by TNF-α and IL-1β in adult rat ventricular myocytes. Am J Physiol Heart Circ Physiol 44, H1462-1472.
31. 2+ channel current in rat ventricular myocytes by terfenadine. Circ Res 81, 202-210.
32. 2+ current by interleukin-1β in cultured rat ventricular myocytes. Am J Physiol Cell Physiol 268, C339-349.
33. Massion PB & Balligand JL (2003). Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. J Physiol 546, 63.
34. Massion PB, Feron O, Dessy C & Balligand JL (2003). Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93, 388-398.
35. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268, 26286-26295.
36. Mészáros LG, Minarovic I & Zahradnikova A (1996). Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Lett 380, 49-52.
37. Neumann F-J, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M & Schömig A (1995). Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92, 748-755.
38. Ostrom RS, Bundey RA & Insel PA (2004). Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent upon lipid rafts and caveolin signaling complexes. J Biol Chem 279, 19846-19853.
39. Ostrowski E, Rohde T, Zacho M, Asp S & Pedersen BK (1998). Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 508, 949-953.
40. Pedersen BK, Steensberg A, Keller P, Keller C, Fischer C, Hiscock N, Van Hall G, Plomgaard P & Febbraio MA (2003). Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects. Pflugers Arch 446, 9-16.
41. Pouvreau S, Allard B, Berthier C & Jacquemond V (2004). Control of intracellular calcium in the presence of nitric oxide donors in isolated skeletal muscle fibres from mouse. J Physiol 560, 779-794.
42. Prabhu SD, Azimi A & Frosto T (1999). Nitric oxide effects on myocardial function and force-interval relations: Regulation of twitch duration. J Mol Cell Cardiol 31, 2077-2085.
43. Roig E, Orus J, Pare C, Azqueta M, Filella X, Perez-Villa F, Heras M & Sanz G (1998). Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 82, 688-690.
44. Rosendal L, Sogaard K, Kjaer M, Sjogaard G, Langberg H & Kristiansen J (2005). Increase in interstitial interleukin-6 of human skeletal muscle with repetitive low-force exercise. J Appl Physiol 98, 477-481.
45. Saito H, Patterson C, Hu Z, Runge MS, Tipnis U, Sinha M & Papaconstantinou J (2000). Expression and self-regulatory function of cardiac interleukin-6 during endotoxemia. Am J Physiol Heart Circ Physiol 279, H2241-2248.
46. Satoh M, Tamura G, Segawa I, Tashiro A, Hiramori K & Satodate R (1996). Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy. Virchows Arch 427, 503-509.
47. Sawa Y, Ichikawa H, Kagisaki K, Ohata T & Matsuda H (1998). Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J Thorac Cardiovasc Surg 116, 511-517.
48. Steele IC, Nugent AM, Maguire S, Hoper M, Campbell G, Halliday MI & Nicholls DP (1996). Cytokine profile in chronic cardiac failure. Eur J Clin Invest 26, 1018-1022.
49. Stojanovic MO, Ziolo MT, Wahler GM & Wolska BM (2001). Anti-adrenergic effects of nitric oxide donor SIN-1 in rat cardiac myocytes. Am J Physiol Cell Physiol 281, C342-349.
50. Sugishita K, Kinugawa K, Shimizu T, Harada K, Matsui H, Takahashi T, Serizawa T & Kohmoto O (1999). Cellular basis for the acute inhibitory effects of IL-6 and TNF-α on excitation-contraction coupling. J Mol Cell Cardiol 31, 1457-1467.
51. Toft AD, Jensen LB, Bruunsgaard H, Ibfelt T, Halkjaer-Kristensen J, Febbraio M & Pedersen BK (2002). Cytokine response to eccentric exercise in young and elderly humans. Am J Physiol Cell Physiol 283, C289-295.
52. Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I & Fischmeister R (1999). Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med 5, 331-334.
53. Wahler GM & Dollinger SJ (1995). Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am J Physiol Cell Physiol 268, C45-54.
54. Wan S, DeSmet JM, Barvais L, Goldstein M, Vincent JL & LeClerc JL (1996). Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 112, 806-811.
55. Werdan K (1998). The activated immune system in congestive heart failure from dropsy to the cytokine paradigm. J Intern Med 243, 87-92.
56. Wollert KC & Drexler H (2001). The role of interleukin-6 in the failing heart. Heart Fail Rev 6, 95-103.
57. Wyeth RP, Temma K, Seifen E & Kennedy RH (1996). Negative inotropic actions of nitric oxide require high doses in rat cardiac muscle. Pflugers Arch 432, 678-684.
58. Xu L, Eu JP, Meissner G & Stamler JS (1998). Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279, 234-237.
59. Xu KY, Huso DL, Dawson TM, Bredt DS & Becker LC (1999). Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 96, 657-662.
60. Yokoyama T, Arai M, Sekiguchi K, Tanaka T, Kanda T, Suzuki T & Nagai R (1999). Tumor necrosis factor-α decreases the phosphorylation levels of phospholamban and troponin I in spontaneously beating rat neonatal cardiac myocytes. J Mol Cell Cardiol 31, 261-273.
61. Yu X-W, Kennedy RH & Liu SJ (2000). Nitric oxide synthase pathway involved in suppression of cardiac contractility during chronic exposure to IL-6. J Mol Cell Cardiol 32, 72.
62. Yu X-W, Kennedy RH & Liu SJ (2003). JAK2/STAT3, not ERK1/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes. J Biol Chem 278, 16304-16308.